Partial cellular reprogramming briefly switches on Yamanaka-factor programs—usually OSK (OCT4, SOX2 and KLF4) or OSKM (OSK plus c-MYC)—then switches them off before a mature cell becomes an induced-pluripotent stem cell. The intended result is a younger epigenetic and transcriptional state while the cell keeps its specialized job.
That result has been demonstrated mainly in cultured cells and mice. Human-cell experiments show molecular age shifts, but no partial-reprogramming treatment has been proven safe or effective in people, and no validated consumer product exists.
As an Amazon Associate I earn from qualifying purchases.
What partial reprogramming actually does
Most adult cells carry two kinds of information. Their genome is the DNA sequence, while epigenetic marks and gene-regulatory networks determine which genes are active in a skin cell, neuron, muscle cell or fibroblast. Aging changes those regulatory layers: DNA-methylation patterns drift, inflammatory genes may become overactive, mitochondrial performance can decline and repair programs can weaken.
Yamanaka factors can reset much of that regulatory state. In conventional reprogramming, sustained expression of OCT4, SOX2, KLF4 and c-MYC drives a differentiated cell toward induced pluripotency. The cell loses its original identity and acquires stem-cell-like properties. Partial reprogramming uses a shorter exposure, lower or targeted expression, a subset such as OSK, or a chemical cocktail. The exposure ends during a proposed “rejuvenation window,” before stable pluripotency and broad dedifferentiation.
#1 Best Overall
- HEAD-TO-HEAD VS NMN: In a head-to-head clinical study at the same dose, Tru Niagen increased blood NAD+ 161% vs. 69% for NMN. (Berven et al. (2026). iScience (Cell Press). University of Bergen, Norway. Crossover design, n=6, 1,200mg/day for 8 days.)
- CLINICALLY SHOWN TO INCREASE NAD+: NAD+ supports cellular energy and healthy aging. Niagen is clinically shown to increase NAD+ levels by up to 150% in 3 weeks (1,000mg).
- THE NR IN THE RESEARCH: The ingredient researchers use most for NR studies is Niagen, used in over 75% of published clinical studies on nicotinamide riboside.
- EVERY BATCH THIRD-PARTY TESTED: If it says Niagen, it's Niagen. Every batch of Tru Niagen is third-party tested. Buy from Tru Niagen's official Amazon store for authentic Niagen.
- HOW TO TAKE: 1 capsule daily (300mg). This pack: 1 bottle of 30 capsules. Made by Niagen Bioscience, the company that pioneered Niagen.
The word partial describes the protocol, not a guarantee. A treatment is successful only if tests show both a younger molecular state and preservation of the cell’s original identity.
Why identity can remain—and why it can still be lost
The timing window
Yamanaka factors activate pluripotency and differentiation genes, increase proliferation and suppress some somatic-identity programs. Early, temporary exposure may reset age-associated regulation without completing that conversion. Longer or stronger exposure can cross the boundary into dedifferentiation, uncontrolled growth or a stem-cell-like state.
How researchers test identity
Identity cannot be inferred from the name OSK or from a younger clock alone. Investigators examine lineage-specific gene expression, cell morphology, specialized functions and whether cells respond normally to stimuli. They also look for pluripotency markers and abnormal proliferation. The same dose can be beneficial in one tissue and harmful in another, so identity testing has to be tissue-specific.
Recommended Free Tools
| Feature | Full OSKM reprogramming | Partial reprogramming |
|---|---|---|
| Exposure | Sustained until pluripotency is established | Brief, cyclic or otherwise limited |
| Intended state | Induced-pluripotent stem cell | Younger differentiated cell |
| Cell identity | Broadly erased and rebuilt | Intended to remain, but must be measured |
| Main opportunity | Generate pluripotent cells for development or disease modeling | Reset age-associated regulation in existing tissue |
| Main danger | Loss of lineage and tumor-forming potential | Overexposure, dedifferentiation, proliferation and tumor formation |
What has been seen in human cells
A 2024 Aging Cell review compiled cell-culture and animal findings and emphasized that results vary by tissue, protocol and clock. The human results below are molecular measurements in laboratory cultures, not clinical outcomes.
| Model and protocol | Reported result | What it does not show |
|---|---|---|
| 60–90-year-old human fibroblasts treated with modified-RNA OSKMLN for four days | Horvath-clock estimate shifted by −1.84 years; the skin-and-blood clock shifted by −1.07 years | It does not establish restored health or a lasting effect in a person |
| Human endothelial cells given the same modified-RNA OSKMLN schedule | Horvath-clock estimate shifted by −4.94 years; the skin-and-blood clock shifted by −1.62 years | Different clocks and cell types do not provide a universal biological-age value |
| Accelerated-aging fibroblast model treated with AAV-OSK | Up to a 57% decrease in measured epigenetic age | This is a laboratory model using a viral vector, not a human therapy |
| Cultured human fibroblasts treated with OSKM for 13 days | About a 30-year reduction in median DNA-methylation-clock age | A large clock shift is not proof that every aging process was reversed |
Those findings indicate that age-associated molecular programs can be moved in human cells. They do not demonstrate that a treated person would live longer, heal faster or avoid age-related disease. Cell cultures also lack an immune system, blood supply, organ architecture and the delivery constraints present in a body.
Rank #2
- Comprehensive Telomere Support: Unlike other telomere supplements that focus on just one aspect of telomere wellness, TelomeMaxtelomere lengthening supplements provides full-spectrum support. Cellular wellness supplement helps with telomere length, protection, maintenance, and cellular resilience, supporting overall cellular vitality for long-term well-being.
- Telomere Length Enhancement: Age support supplements features Organic Astragalus and Gotu Kola, which are known for their ability to support telomere length. These botanicals, rich in antioxidants, are carefully selected to contribute to overall cellular wellness and sustain cellular longevity.
- Telomere Protection & Maintenance: Crafted with Vitamin D3, Folate, Magnesium, and L-Theanine, telomere lengthening supplements helps maintain optimal telomere length, while providing protection against oxidative stress. This combination supports vital cell division and contributes to overall cellular wellness for long-term well-being.
- Synergistic Proprietary Blends for Maximum Effect: Telomere lengthening supplements combines four specialized blends – TeloLong, TeloBalance, TeloGuard, and TeloCalm – each designed to target key aspects of telomere wellness, providing comprehensive support for optimal effectiveness.
- Premium Quality, Made in Japan: Telomere support supplements is made with 100% organic, ingredients ensuring a clean and safe product. Produced under rigorous Japanese manufacturing standards, strong cell supplement designed to the highest purity and quality for best results.
What mouse studies add—and what they cannot predict
Whole-animal experiments test tissue function, side effects and survival, but mouse results remain preclinical. A 2024 Nature Communications review describes cyclic protocols with substantial effects in specific models.
| Mouse experiment | Reported outcome | Qualification |
|---|---|---|
| Cyclic OSKM in a progeric mouse model | Median lifespan increased by 33% | Applies to an accelerated-aging model, not ordinary human aging |
| Cyclic AAV9-delivered OSK in 124-week-old wild-type mice | Remaining lifespan increased by 109% | A mouse survival result; it must not be presented as an expected human lifespan gain |
Animal work also illustrates the danger of assuming that more exposure is better. Responses differ sharply between organs, and the review describes beneficial outcomes in some tissues but lethal outcomes when cardiac OSKM exposure was extended in mice. Dose, schedule, vector distribution and the age or health of the animal all matter.
What “reversing aging” means in these studies
Researchers use several endpoints, and they do not measure the same thing.
- DNA-methylation clocks: statistical estimates based on methylation at selected genomic sites.
- Transcriptomic clocks: age estimates derived from gene-expression patterns.
- Chromatin and gene regulation: changes in histone marks, chromatin accessibility and age-associated genes.
- Cellular function: mitochondrial measures, senescence markers, wound repair or tissue regeneration.
- Organism-level outcomes: vision, frailty, pathology and survival in animals.
A younger clock is a biomarker result. It does not prove that telomeres, mutation burden, protein damage, immune aging and every other component of aging were restored. Clock responses also differ among tissues and among clock algorithms; some tissues show little or no improvement under a protocol that works elsewhere.
OSK versus OSKM: why the factor choice matters
OSK omits c-MYC, a powerful proliferation and transcriptional regulator. OSKM adds c-MYC and may produce stronger or faster reprogramming, but c-MYC also raises concern about uncontrolled proliferation and oncogenic activity. Neither combination is intrinsically safe.
Rank #3
- NAD+ CELLULAR ENERGY SUPPORT: NAD+ is a vital coenzyme involved in hundreds of metabolic processes throughout the body. This supplement is formulated to support cellular energy metabolism and mitochondrial health.
- PRECLINICAL RESEARCH: Based on an independent preclinical animal study, NAD+ preserves content in the liver at 9.31x higher than regular NAD+ . Not confirmed in human studies.
- THIRD-PARTY TESTED QUALITY: Every batch is tested in the USA for heavy metals and safety to ensure consistent quality and manufacturing standards.
- CLEAN MANUFACTURING STANDARDS: Made and packaged in the USA from globally sourced ingredients under strict quality control processes.
- 30-DAY SUPPLY – 60 CAPSULES: Each bottle provides a full month supply with a simple two-capsule daily serving for easy daily use.
| Decision axis | OSK | OSKM |
|---|---|---|
| Identity preservation | Often selected when a narrower reset is desired; still protocol-dependent | Potentially more forceful; longer exposure increases dedifferentiation risk |
| c-MYC-related concern | Does not include c-MYC | Includes c-MYC, adding a direct proliferation and oncogenic-risk concern |
| Delivery examples | AAV vectors, modified RNA or targeted expression systems | AAV, RNA or inducible genetic systems |
| Exposure strategy | Usually transient or cyclic in rejuvenation experiments | Must be tightly limited; prolonged cardiac exposure was lethal in one mouse context |
| Evidence base | Human-cell molecular results and mouse tissue or survival studies | Human-cell clock results and mouse reprogramming studies |
Genetic delivery versus chemical cocktails
Genetic approaches deliver factor instructions through viral vectors, modified RNA or other expression systems. Chemical approaches use small molecules to influence the same reprogramming circuitry without introducing factor genes. Each has a different control problem.
| Approach | Potential advantage | Key limitation |
|---|---|---|
| Viral factor delivery | Can produce strong, sustained expression in reachable cells | Distribution, dose control, immune reactions and prolonged expression are difficult; some vectors can persist |
| Modified RNA | Transient instructions with no requirement for genomic integration | Repeated dosing and delivery to enough cells remain difficult |
| Small-molecule cocktails | Potentially reversible and easier to titrate than gene expression | Off-target pharmacology, tissue penetration and human safety still need to be established |
A 2023 chemical-reprogramming study reported six small-molecule cocktails that, in less than a week, restored a youthful genome-wide transcript profile and reversed transcriptomic age in human-cell assays without compromising measured cellular identity. That is an important proof of principle, but it remains a cell assay rather than a treatment tested in people.
How a real therapy would have to be controlled
A safe protocol would be more than “turn on the factors.” It would require a sequence of controls:
- Select a tissue and target cells. A therapy would need a defined disease or aging target, such as a particular senescent-cell population, rather than indiscriminate body-wide expression.
- Choose a reversible delivery system. Investigators must know how quickly expression starts, how long it lasts and how it can be stopped.
- Calibrate the rejuvenation window. Dose and exposure must be long enough to change age-associated programs but short enough to avoid stable pluripotency.
- Verify identity during treatment. Lineage markers, specialized function, morphology and pluripotency markers should be checked in the same tissue.
- Screen for abnormal growth. Long-term follow-up must look for clonal expansion, dysplasia, teratomas and cancers, not only immediate toxicity.
- Measure function, not just clocks. Tissue repair, organ performance and clinically meaningful outcomes must accompany epigenetic or transcriptomic measurements.
- Track durability after withdrawal. Cells might retain the younger state, revert to their prior state or age faster after the intervention stops.
Main safety barriers
Uncontrolled proliferation and tumors
Continuous Yamanaka-factor expression can activate pluripotency and differentiation genes while suppressing somatic identity. In vivo, that combination can produce teratomas or other tumors. c-MYC adds a separate concern because it promotes proliferation.
Loss of specialized function
A cell that looks younger on a clock but no longer performs its tissue role is not a successful rejuvenation. Partial conversion can be subtle, so functional tests and long observation are essential.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Rank #4
- Healthy Aging: Supports cellular repair, up-regulates sirtuin proteins for detoxification benefits, boosts NAD+ production, and enhances cellular energy production in the mitochondria to support the aging process*
- Unique Ingredients: Formulated with a unique form of nicotinamide riboside (NR) to protect against DNA damage, resveratrol for stress resistance, and quercetin to help reduce cellular senescence*
- NAD+ Support: Stimulates the production of NAD+, an important coenzyme that declines significantly with age but plays an integral role in every cell throughout the body, including for cellular repair and normal circadian rhythm function*
- Third-Party Certified: This product has been third-party tested and certified to verify what's in the package matches what's on the label and to confirm it contains no unsafe levels of contaminants
- Trusted: Thorne is trusted by 100+ professional sports teams and the #1 most recommended clinical brand by consumers and health-care practitioners (Based on a 2026 independent survey of US supplement consumers and health-care practitioners)
Uneven delivery
Viral and RNA systems may reach only a fraction of target cells. Organs also differ in blood flow, barriers, receptor expression and immune clearance. A dose that is too low may do nothing; a dose concentrated in one organ may cause damage.
Tissue-specific toxicity
The same factors can produce different outcomes in skin, liver, muscle, brain or heart. Beneficial findings in one tissue cannot be generalized to the whole body, and the lethal cardiac result in mice shows why exposure schedules require organ-by-organ testing.
Is the rejuvenation permanent?
No durable answer has been established. The reviewed evidence identifies an open question: after factor withdrawal, do cells maintain the younger state, return completely to their previous state or lose the youthful program faster than untreated cells? The available partial-reprogramming evidence also has not resolved telomere attrition. A younger methylation or transcriptomic signature therefore should not be described as permanent age reversal.
Are Yamanaka factors an anti-aging treatment yet?
No. OSK, OSKM, AAV vectors, modified RNA constructs and chemical cocktails are experimental laboratory interventions. They are not validated home treatments, supplements or over-the-counter products. A legitimate clinical program would need regulatory authorization, defined manufacturing, controlled dosing, identity-preservation assays and long-term tumor surveillance.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchPC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11A 2025 PubMed-indexed commentary describes targeted OSK delivery to Cdkn2a-positive cells as a way to rejuvenate senescent cells while maintaining identity, with supporting observations involving inflammation-associated genes in human fibroblasts. This remains a preclinical report, not evidence of an approved intervention.
How to judge a claim about “age reversal”
- Ask whether the result came from human cells, a normal animal, an accelerated-aging animal or people.
- Identify the endpoint: a DNA-methylation clock, gene expression, tissue function, disease measure or survival.
- Check the factor combination, delivery vehicle, dose and exposure schedule.
- Look for direct tests of lineage identity and pluripotency, not a clock result alone.
- Check whether the follow-up period was long enough to detect tumors and loss of function.
- Separate a one-time laboratory measurement from a reproducible, durable clinical benefit.
The most accurate conclusion is narrow but significant: cells can be pushed toward younger molecular states without necessarily becoming stem cells, yet preserving identity is an experimental outcome that must be demonstrated for each tissue and protocol.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
